Switching of Oral P2Y12 Inhibitor Treatment in Patients with Acute Coronary Syndrome: Prevalence, Predictors, and Prognosis

被引：0
|
作者：
Luna Carrillo-Aleman
Francisco Marín
José M. Rivera-Caravaca
Nuria Vicente-Ibarra
Elena Candela-Sanchez
Maria A. Esteve-Pastor
Teresa Lozano
Miriam Sandín-Rollan
Vicente Pernias-Escrig
Manuel Macías
Miriam Quintana-Giner
Andrea Veliz
Esteban Orenes-Piñero
Juan G. Martínez-Martínez
Juan M. Ruiz-Nodar
机构：
[1] Hospital General Universitario de Alicante,Department of Cardiology
[2] Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL),Department of Cardiology
[3] Hospital Clínico Universitario Virgen de la Arrixaca,Department of Cardiology
[4] Instituto Murciano de Investigación (IMIB-Arrixaca),undefined
[5] CIBER-CV,undefined
[6] Hospital General Universitario de Elche,undefined
来源：
Clinical Drug Investigation | 2019年 / 39卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：275 / 283
页数：8
相关论文
共 50 条
  • [1] Switching of Oral P2Y12 Inhibitor Treatment in Patients with Acute Coronary Syndrome: Prevalence, Predictors, and Prognosis
    Carrillo-Aleman, Luna
    Marin, Francisco
    Rivera-Caravaca, Jose M.
    Vicente-Ibarra, Nuria
    Candela-Sanchez, Elena
    Esteve-Pastor, Maria A.
    Lozano, Teresa
    Sandin-Rollan, Miriam
    Pernias-Escrig, Vicente
    Macias, Manuel
    Quintana-Giner, Miriam
    Veliz, Andrea
    Orenes-Pinero, Esteban
    Martinez-Martinez, Juan G.
    Ruiz-Nodar, Juan M.
    CLINICAL DRUG INVESTIGATION, 2019, 39 (03) : 275 - 283
  • [2] In-hospital switching of oral P2Y12 inhibitor treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: Prevalence, predictors and short-term outcome
    Alexopoulos, Dimitrios
    Xanthopoulou, Ioanna
    Deftereos, Spyridon
    Sitafidis, George
    Kanakakis, Ioannis
    Hamilos, Michalis
    Angelidis, Christos
    Petousis, Stylianos
    Stakos, Dimitrios
    Parissis, Haralambos
    Vavouranakis, Manolis
    Davlouros, Periklis
    Goudevenos, John
    Stefanadis, Christodoulos
    AMERICAN HEART JOURNAL, 2014, 167 (01) : 68 - +
  • [3] In-Hospital Switching Of Oral P2Y12 Inhibitor Treatment In Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Prevalence, Predictors And Short-Term Outcome
    Alexopoulos, Dimitrios
    Xanthopoulou, Ioanna
    Deftereos, Spyridon
    Sitafidis, Georgios
    Kanakakis, Ioannis
    Hamilos, Michalis
    Angelidis, Christos
    Petousis, Stylianos
    Stakos, Dimitrios
    Parisis, Charalambos
    Vavuranakis, Manolis
    Davlouros, Periklis
    Goudevenos, John
    Stefanadis, Christodoulos
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B51 - B51
  • [4] P2Y12 Inhibitor Adherence Patterns in Patients with Acute Coronary Syndrome
    Ozaki, Aya
    Ko, Dennis T.
    Chong, Alice
    Fang, Jiming
    Austin, Peter
    Sud, Maneesh
    Jackevicius, Cynthia A.
    CIRCULATION, 2021, 144
  • [5] Assessment of P2Y12 inhibitor usage and switching in acute coronary syndrome patients undergoing percutaneous coronary revascularization
    Kudaravalli, Mrudula
    Althouse, Andrew D.
    Marroquin, Oscar C.
    Khandhar, Sameer J.
    Sharbaugh, Michael S.
    Toma, Catalin
    Smith, A. J. Conrad
    Schindler, John T.
    Lee, Joon S.
    Mulukutla, Suresh R.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 223 : 854 - 859
  • [6] Comparison of Oral P2Y12 Inhibitors in Acute Coronary Syndrome
    Ferracane, Elisa
    Bartoli, Laura
    Trippoli, Sabrina
    Messori, Andrea
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 135 : 183 - 184
  • [7] Switching of P2Y12 inhibitor in patients with acute coronary syndrome: Insights from the GReek AntiPlatElet Registry (GRAPE)
    Xanthopoulou, I.
    Perperis, A.
    Stavrou, K.
    Siapika, A.
    Ntalas, I.
    Petousis, S.
    Angelidis, C.
    Parissis, H.
    Alexopoulos, D.
    EUROPEAN HEART JOURNAL, 2013, 34 : 884 - 885
  • [8] P2Y12 inhibitor in acute coronary syndromes
    Wiwanitkit, Viroj
    NATIONAL MEDICAL JOURNAL OF INDIA, 2013, 26 (04): : 249 - 249
  • [9] Selection of P2Y12 Inhibitor in Percutaneous Coronary Intervention and/or Acute Coronary Syndrome
    Tantry, Udaya S.
    Navarese, Eliano P.
    Myat, Aung
    Gurbel, Paul A.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2018, 60 (4-5) : 460 - 470
  • [10] What Are Optimal P2Y12 Inhibitor and Schedule of Administration in Patients With Acute Coronary Syndrome?
    Cohen, Michael V.
    Downey, James M.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2020, 25 (02) : 121 - 130
12345